Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201202121 Principal Investigator: Govindan, Ramaswamy
Title: Phase Ib / II study of BAY 1000394 in combination with cisplatin / etoposide or carboplatin / etoposide as first-line therapy in subjects with extensive disease small cell lung cancer
Phase: I/II Disease Site: Lung
Participating Site(s):
 
Main Campus
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of the first part this study is to determine the safety, tolerability, and best dose of the study drug, BAY 1000394 in combination with chemotherapy drugs cisplatin plus etoposide or carboplatin plus etoposide chemotherapy.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)